Aptevo Therap

APVO
0.785027.31% ( -0.2950 )
Trading: Nov 11, 13:36:44 (EDT)

Current ValuationThe current P/E ratio is -0.07, within the reasonable range, cheaper than 23.79% of the time in the past 5 years, and the industry ranks 91/606, the industry Median -1.82.

-0.0738xP/E
Stock price$1.08Earnings per share$-14.64

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-54.88x162.77%$211.94B
MRNAUSModerna
-35.91x3.57%$100.14B
CSLLYUSCSL Limited
-25.59x--$65.99B
NTRAUSNatera
-274.65x0.99%$45.24B
RVMDUSRevolution Medicines
-22.12x40.80%$41.38B
ROIVUSRoivant Sciences
-86.67x67.79%$29.84B
INSMUSInsmed
-43.28x74.47%$26.21B
BNTXUSBioNTech SE
-12.78x29.90%$21.62B
BBIOUSBridgebio Pharma
-25.88x30.83%$15.32B
SMMTUSSummit Therapeutics
-17.08x23.12%$14.22B
KYMRUSKymera Therapeutics
-32.52x8.74%$11.36B
BMRNUSBioMarin Pharma
-578.91x61.50%$11.07B
PCVXUSVaxcyte
-9.15x44.27%$10.50B
MDGLUSMadrigal Pharma
-64.64x87.15%$10.05B
SYREUSSpyre Therapeutics
-44.30x59.92%$9.92B
PRAXUSPraxis Precision Medicines
-26.22x0.71%$9.43B
TWSTUSTwist Bioscience
-63.62x28.63%$8.70B
RYTMUSRhythm Pharma
-39.84x51.65%$7.90B
CYTKUSCytokinetics
-10.06x8.57%$7.83B
ALKSUSAlkermes
-22,247.82x133.59%$7.81B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.